Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

NDC Numbers: A New Approach

Author(s):  Heckman H Edward

Issue:  Sep/Oct 2003 - After the Women's Health Initiative Trial
View All Articles in Issue

Page(s):  358-359

NDC Numbers: A New Approach Page 1
NDC Numbers: A New Approach Page 2

Download in electronic PDF format for $75

Abstract:  The author discusses the dilemma of compounding pharmacists involving the use (or lack of use) of National Drug Code numbers in terms of challenges for payment. He suggests a two-pronged strategy to meet this challenge, saying that both strategies must be employed together to successfully eliminate unfair business practices associated with National Drug Code numbers. The first prong of the strategy involves changing the billing methodology of compounds from a drug to a service. The second involves fielding a solid front to stop the current payment practices by third parties and steering them to the new payment paradigm. He concludes that changes in coding claims and a solid pharmacy community united to gain fair treatment will be necessary, and ends with a call to action to pharmacists to unite on this issue.

Related Keywords: NDC (National Drug Code), National Drug Code

Related Categories: SUPPORT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
NDC Numbers: A New Approach
Heckman H Edward
Sep/Oct 2003
Pg. 358-359

Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting
Medi-Dose Inc./EPS Inc.
Sep/Oct 2017
Pg. 384-387

Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
May/Jun 2013
Pg. 201-204

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Kramer Mark A
, Grilley Bambi J
Jul/Aug 2002
Pg. 271-273

The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase
, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015
Pg. 377-380

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust
Guedes de Souza Hugo
, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
Nov/Dec 2009
Pg. 532-536

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Jan/Feb 2008
Pg. 74-82

Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
Jan/Feb 2008
Pg. 38-47

View Sample
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Allen Loyd V Jr
Jul/Aug 2007
Pg. 350-351

Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448

Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor
Allen Loyd V Jr
May/Jun 2004
Pg. 162

Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
Mar/Apr 2001
Pg. 101-103

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Return to Top